AI tool for computing radiation dose helps personalize prostate cancer treatment

Radiopharmaceutical therapy (RPT) has made significant strides over the past 50 years, although it only recently received FDA approval to treat prostate cancer. But despite the progress—and billions of dollars in industry investments—one area that has lagged behind is dosing,…

Radiopharmaceutical therapy (RPT) has made great strides over the last 50 years, having only recently received FDA approval to treat prostate cancer. But despite the progress-and billions of dollars of industry investments-one area that has lagged behind is dosing, which is…